The best-selling drugs of the next 5 years - Pharma Excipients
Merck & Co’s immuno-oncology drug Keytruda (pembrolizumab) is projected to be the best-selling drug by annual revenue in 2023, earning $22.2 billion
Merck & Co’s immuno-oncology drug Keytruda (pembrolizumab) is projected to be the best-selling drug by annual revenue in 2023, earning $22.2 billion by 2025, according to new research by GlobalData.Article by pharmaphorum.comThe data forecasts th
New Drug Modalities 2023
Biggest blockbuster drugs of 2020 : Drug sales and beyond – Pharmaceutical Marketing and Strategies for Today
Overcoming Analytical Challenges in High Potency Formulation
Vietnam's pharmaceutical industry: challenges and opportunities in 2023
Forecast of TOP 10 global best-selling drugs in 2021
Pharmaceutical Excipients Market Size, Share, Trends and Revenue Forecast [Latest]
Top 10 Projected Best-Selling Drugs in 2024
Biggest blockbuster drugs of 2020 : Drug sales and beyond – Pharmaceutical Marketing and Strategies for Today
Top 10 Most Anticipated Drug Launches Of 2024
Annual Report 2021